Yossi Maimon Insider Trading
Get free email notifications about insider trading for Yossi Maimon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yossi Maimon. Yossi Maimon is a VP, Chief Financial Officer in Protalix BioTherapeutics, Inc. ($PLX).
Address: C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET SCIENCE PARK, POB 455 CARMIEL 20100Israel
Companies in which Yossi Maimon is an Insider
Protalix BioTherapeutics, Inc.
Trading Symbol: PLXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Yossi Maimon: VP, Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 13 2009
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Yossi Maimon
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 13 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | M | 0.97 | 39,800 | 38,686 | 493,996 | |
Mar 13 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 2.23 | 7,500 | 16,725 | 0 | 7.5 K to 0 (-100.00 %) |
Mar 13 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Payment of Exercise | F | 2.16 | 17,910 | 38,686 | 0 | 17.9 K to 0 (-100.00 %) |
Mar 13 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Buy | M | 0.97 | 39,800 | 38,686 | 0 | -39,800 to 0 (-100.00 %) |
Mar 13 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 2.22 | 32,241 | 71,575 | 0 | 32.2 K to 0 (-100.00 %) |
Mar 13 2009 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 2.30 | 8,849 | 20,353 | 0 | 8.8 K to 0 (-100.00 %) |